HONG KONG – A modified version of the revolutionary gene-editing system known as clustered regularly interspaced short palindromic repeats – cellular apoptosis susceptibility protein (CRISPR/Cas), allows researchers to perform DNA substitutions without actually cleaving the DNA, according to a new Japanese study led by researchers at the University of Kobe. Read More
NEW DELHI – India’s drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), has fixed price caps on 24 essential drugs used for the treatment of cancer, HIV, bacterial infections, anxiety and cardiac conditions, a move that is expected to cut the government’s costs by a quarter. Read More
HONG KONG – Two research teams have independently identified a specialized cytotoxic killer T-cell population and shown that boosting the number and killing ability of those cells may lead to an effective treatment for currently incurable lifelong viral infections, notably HIV. Read More
Scinopharm Taiwan Ltd., of Taiwan, and Cvie Therapeutics Ltd., of Taiwan, said they initiated a discovery and development collaboration to identify a new generation compound to Istaroxime, Cvie’s acute heart failure treatment currently in late phase IIb trials in Italy and China. The primary goal will be to develop a compound possessing oral bioavailability while maintaining Istaroxime’s dual inotropic (myocyte contraction) and lusotropic (myocyte relaxation) function. Read More
